
Qupet 1% w/w10 gm
Incepta Pharmaceuticals Ltd.
Ozenoxacin is an FDA-approved topical antibiotic indicated for the treatment of impetigo caused by susceptible isolates of Staphylococcus aureus (methicillin-susceptible strains) or Streptococcus…
Ozenoxacin is an FDA-approved topical antibiotic indicated for the treatment of impetigo caused by susceptible isolates of Staphylococcus aureus (methicillin-susceptible strains) or Streptococcus pyogenes in adult and pediatric patients within the approved age range.
There is no well-established off-label use for Ozenoxacin; it should be used strictly for its approved topical dermatologic indication.
| Indication | Population | Dose |
|---|---|---|
| Impetigo (due to S. aureus or S. pyogenes) | Adults and pediatric patients ≥2 months of age | Apply a thin layer of 1% Ozenoxacin cream to the affected area twice daily for 5 consecutive days |
Administration instructions:
Topical Ozenoxacin is generally well tolerated. Reported adverse effects are typically mild and local.
If severe irritation, blistering, or signs of an allergic reaction occur, discontinue Ozenoxacin and consult a physician promptly.
Ozenoxacin is contraindicated in patients with known hypersensitivity to ozenoxacin, any other quinolone antibacterial agent, or any component of the formulation.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.